EBA supports the operations of the Blood Establishments by identifying best practices. EBA members strive collectively to improve the supply of blood products and, where provided by members, other substances of human origin (SOHOs).
- Business continuity and sustainability based on Voluntary Non-Remunerated Blood Donations
Business continuity is part of ensuring a sustainable supply of products in all situations. EBA facilitates sharing of back-up arrangements with templates and sharing information on issues with technologies.
VNRD reflects the European value of a broad altruistic donor population securing the continuation of the European blood supply.
- Tissues, cells, advanced therapies and new opportunities
With horizon scanning and business intelligence reports, EBA supports members efforts to invest in new therapeutic fields, leveraging on the members’ experience with donors and blood product manufacturing. EBA also facilitates building a network for ATMP production. Further, EBA supports members by providing information on new technologies and best practices pertaining to quality and safety of SOHOs.
- Performance improvement through benchmarking/lean management
Benchmarking has been part of EBA operations since long. The scope of benchmarking will be expanded from delivering benchmarking data and organising workshops and “flying squad” visits to also comprise a focus on quality management and assist members with self-assessment schemes and self-auditing schemes.
- Advising European Union (EU) institutions
EBA has since its inception been the one voice to EU Institutes for the members. With the current evaluation and possible revision of the EU Directives for Blood, Tissues and Cells this is still the case. The power of the EBA lies in the facts that EBA has a wide network which can be leveraged for political matters, the sourcing of the best experts for regulatory support and relying on scientific evidence, where available.
GOAL: high-performing blood, tissues and cells services within an equitable and predictable working environment in European blood, tissues and cells sector.